Making a Case for the Cost-Effectiveness of Pharmacogenetic Testing in Taiwan Imagine there is a relatively common allele in Southeast Asian populations that puts carriers at a thousand-fold risk of developing a debilitating disease as a result of taking a… Continue reading →